Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y [Yahoo! Finance]
Arcadia Biosciences, Inc. (RKDA)
Last arcadia biosciences, inc. earnings: 3/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arcadiabio.com
Company Research
Source: Yahoo! Finance
RKDA reported a loss per share of $6.31 in the fourth quarter of 2022. The improvement in the bottom line was mainly attributed to lower operating expenses. Net loss attributable to common stockholders in the fourth quarter of 2023 was $2.10 per share compared with $6.31 in the fourth quarter of 2022. Net sales were $1.17 million in the quarter under review, which marked a 57% increase from the year-ago quarter, driven by higher GoodWheat and GLA revenues. The top line missed the Zacks Consensus Estimate of $2 million. Operating expenses declined 16% year over year to $4.5 million in the quarter, attributed to a decline in the cost of revenues and selling, general and administrative (SG&A) expenses. The cost of revenues declined year over year in the fourth quarter of 2023 as the comparable year-ago quarter included higher inventory write-downs. SG&A expenses declined owing to lower employee costs in the quarter under review. The expenses have declined for two straight years and
Show less
Read more
Impact Snapshot
Event Time:
RKDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RKDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RKDA alerts
High impacting Arcadia Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RKDA
News
- Arcadia Biosciences, Inc. (NASDAQ: RKDA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call [Yahoo! Finance]Yahoo! Finance
- Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference CallBusiness Wire
- Arcadia Biosciences, Inc. (NASDAQ: RKDA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Arcadia Biosciences, Inc. (NASDAQ: RKDA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
RKDA
Earnings
- 11/9/23 - Beat
RKDA
Analyst Actions
- 4/5/24 - HC Wainwright
RKDA
Sec Filings
- 4/29/24 - Form 10-K/A
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- RKDA's page on the SEC website